Skip to content
← Back to this collection

PUBLICATIONS · 9792152

A randomized trial comparing methotrexate and vinblastine (MV) with cisplatin, methotrexate and vinblastine (CMV) in advanced transitional cell carcinoma: results and a report on prognostic factors in a Medical Research Council study. MRC Advanced Bladder Cancer Working Party.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Br J Cancer
Publication date
1998 Oct
First author
Mead GM

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Mead GM
      type
      Author
    2. name
      Russell M
      type
      Author
    3. name
      Clark P
      type
      Author
    4. name
      Harland SJ
      type
      Author
    5. name
      Harper PG
      type
      Author
    6. name
      Cowan R
      type
      Author
    7. name
      Roberts JT
      type
      Author
    8. name
      Uscinska BM
      type
      Author
    9. name
      Griffiths GO
      type
      Author
    10. name
      Parmar MK
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Mead GM
      type
      Author
    2. name
      Russell M
      type
      Author
    3. name
      Clark P
      type
      Author
    4. name
      Harland SJ
      type
      Author
    5. name
      Harper PG
      type
      Author
    6. name
      Cowan R
      type
      Author
    7. name
      Roberts JT
      type
      Author
    8. name
      Uscinska BM
      type
      Author
    9. name
      Griffiths GO
      type
      Author
    10. name
      Parmar MK
      type
      Author
    bibliography ids
    1. nci-bib-7ac3212f7fe6381b25b8761a
    book metadata
    content sha256
    858f50d5689d01da0109e7afa24afd98dd55d710b70775a1b4b77aa16462a871
    document type
    citation
    dois
    1. 10.1038/bjc.1998.629
    electronic publication date
    display
    Source null
    precision
    missing
    year
    Source null
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:9792152
    immutable id
    pubmed:9792152@858f50d5689d01da0109e7afa24afd98dd55d710b70775a1b4b77aa16462a871
    journal
    abbreviation
    Br J Cancer
    issn electronic
    1532-1827
    issn print
    0007-0920
    issue
    8
    name
    British journal of cancer
    nlm unique id
    0370635
    pages
    1067-75
    volume
    78
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      9792152
      provenance
      batch id
      7e001e36165c25a91a06
      provider
      NCBI PubMed ESummary
      record sha256
      107a79c2796c2c3c7e726aa0db065d67d386e489a9b12f9bf2bacad085bab3b5
      response sha256
      3515b9c50c264ae766881ea5a6c5cb10e3af8e45341fd57a5bedfa1946d08222
      retrieved at
      2026-09-09T23:45:31.509029+00:00
      publication date
      display
      1998 Oct
      precision
      month
      year
      1998
      publication types
      1. Clinical Trial
      2. Comparative Study
      3. Journal Article
      4. Multicenter Study
      5. Randomized Controlled Trial
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/9792152/
      title
      A randomized trial comparing methotrexate and vinblastine (MV) with cisplatin, methotrexate and vinblastine (CMV) in advanced transitional cell carcinoma: results and a report on prognostic factors in a Medical Research Council study. MRC Advanced Bladder Cancer Working Party.

      Preserved source evidence · Not medical advice